Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) EBIT Margin (2020 - 2025)

Pulse Biosciences (PLSE) has 4 years of EBIT Margin data on record, last reported at 6914.02% in Q4 2025.

  • For Q4 2025, EBIT Margin changed N/A year-over-year to 6914.02%; the TTM value through Dec 2025 reached 21982.57%, changed N/A, while the annual FY2025 figure was 21982.57%, N/A changed from the prior year.
  • EBIT Margin reached 6914.02% in Q4 2025 per PLSE's latest filing, up from 23682.56% in the prior quarter.
  • Across five years, EBIT Margin topped out at 97166.67% in Q4 2022 and bottomed at 23682.56% in Q3 2025.
  • Average EBIT Margin over 3 years is 8021.43%, with a median of 2486.59% recorded in 2021.
  • Peak YoY movement for EBIT Margin: surged 22744084bps in 2021, then plummeted -2014032bps in 2022.
  • A 3-year view of EBIT Margin shows it stood at 1825.83% in 2021, then surged by 5422bps to 97166.67% in 2022, then crashed by -107bps to 6914.02% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 6914.02% in Q4 2025, 23682.56% in Q3 2025, and 97166.67% in Q4 2022.